(Total Views: 211)
Posted On: 10/13/2017 11:12:40 AM
Post# of 72443
We know that in the past, at least 2 big pharmas have been shown to be involved in these kinds of activities. Their goal is to keep the share price low, so that they can either force the company to take toxic financing that bankrupts them, or, so that they can force the company into taking an extreme lowball offer for their intellectual property.
Want an example? Look at OCAT, forced to take a horrible deal after they were attacked by..... Mako.
Fortunately Leo Ehrlich has avoided putting the company into either position. They are not going to succeed in their attempt to force a lowball deal. We have money in hand and financing assured for the future, so Leo is NOT going to take a bad deal.
If you think this is a conspiracy theory, I assure you it is not. I don't feel like getting sued so I'm not posting the names of the 2 big pharmas that have been implicated in this in the past, but if you PM me I'll be glad to discuss it.
I believe that some big pharma has financed this attack via cut-outs and offshore accounts that have helped Mako and others. That's how they've done it with other companies they've attacked.
Want an example? Look at OCAT, forced to take a horrible deal after they were attacked by..... Mako.
Fortunately Leo Ehrlich has avoided putting the company into either position. They are not going to succeed in their attempt to force a lowball deal. We have money in hand and financing assured for the future, so Leo is NOT going to take a bad deal.
If you think this is a conspiracy theory, I assure you it is not. I don't feel like getting sued so I'm not posting the names of the 2 big pharmas that have been implicated in this in the past, but if you PM me I'll be glad to discuss it.
I believe that some big pharma has financed this attack via cut-outs and offshore accounts that have helped Mako and others. That's how they've done it with other companies they've attacked.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
Scroll down for more posts ▼